FIELD: immunology.
SUBSTANCE: present invention relates to immunology. What is presented is an antibody or its antigen-binding fragment specifically binding GD2 ganglioside. Also contemplated is a multivalent construct and a method of detecting GD2 ganglioside.
EFFECT: present invention can find further application in diagnosis and therapy of GD2-positive oncological diseases.
8 cl, 13 dwg, 2 tbl,10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRODUCING PEGYLATED FRAGMENTS OF GD2-SPECIFIC ANTIBODIES INDUCING DIRECT CELL DEATH OF GD2-POSITIVE TUMOR CELLS, AND USE THEREOF IN THERAPY OF GD2-POSITIVE TUMORS | 2017 |
|
RU2663104C1 |
| CREATION OF CONJUGATES OF GD2-SPECIFIC ANTIBODIES AND FRAGMENTS OF GD2-SPECIFIC ANTIBODIES WITH PREPARATIONS | 2019 |
|
RU2733430C1 |
| GD2 BINDING MOLECULE | 2020 |
|
RU2824670C2 |
| USE OF O-ACETYLATED GD2 GANGLIOSIDE AS TARGET AS NOVEL THERAPEUTIC AND DIAGNOSTIC APPROACH IN MALIGNANT GROWTHS CONTAINING TUMOUR STEM CELLS | 2014 |
|
RU2702428C2 |
| USE OF MONOCLONAL ANTIBODIES SPECIFIC TO O-ACETYLATED FORM OF GANGLIOSIDE GD2 FOR TREATING CERTAIN FORMS OF CANCER | 2007 |
|
RU2462476C2 |
| GENETIC CONSTRUCT CODING STRUCTURE OF T-CELL CHIMERIC RECEPTOR BASED ON SINGLE-CHAIN VHH ANTIBODIES SPECIFIC TO TUMOUR RECEPTOR CD47 FOR THE TARGETED IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2017 |
|
RU2707535C2 |
| ANTIBODY RAISED AGAINST TO HUMAN GASTROENTERIC TRACT EPITHELIAL TUMOR ANTIGEN RELATED WITH ALPHA-6,BETA-4-INTEGRIN | 2000 |
|
RU2266298C2 |
| ANTI-CD 16 BINDING MOLECULES | 2006 |
|
RU2491294C2 |
| MONOCLONAL ANTIBODIES AND ONE-CHAIN FRAGMENTS OF CELL-SURFACE PROSTATE-SPECIFIC MEMBRANE ANTIGEN ANTIBODIES | 2006 |
|
RU2458073C2 |
| ANTIBODIES DIRECTED AT EPITOPES LOCATED IN AREA OF 160-200 AMINO ACID BASES OF HUMAN PRAME PROTEIN, AND THEIR APPLICATION | 2019 |
|
RU2774194C2 |
